Direct comparison of in vivo fate of second and third-generation CD19-specific chimeric antigen receptor (CAR)-T cells in patients with b cell non-hodgkin lymphoma (B-NHL): Reversa... von Gomes da Silva, D, Mukherjee, M, Madhuwanti, S, Dakhova, O, Liu, H, Grilley, B, Gee, A, Neelapu, S.S, Rooney, C, Heslop, H, Savoldo, B, Dotti, G, Brenner, M, Mamonkin, M, Ramos, C.A

Volltext

Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccines von Park, H.J, Qin, H, Cha, S.C, Sharma, R, Chung, Y, Schluns, K.S, Neelapu, S.S, Overwijk, W.W, Hwu, P, Kwak, L.W

Volltext

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma von Neelapu, Sattva S, Locke, Frederick L, Bartlett, Nancy L, Lekakis, Lazaros J, Miklos, David B, Jacobson, Caron A, Braunschweig, Ira, Oluwole, Olalekan O, Siddiqi, Tanya, Lin, Yi, Timmerman, John M, Stiff, Patrick J, Friedberg, Jonathan W, Flinn, Ian W, Goy, Andre, Hill, Brian T, Smith, Mitchell R, Deol, Abhinav, Farooq, Umar, McSweeney, Peter, Munoz, Javier, Avivi, Irit, Castro, Januario E, Westin, Jason R, Chavez, Julio C, Ghobadi, Armin, Komanduri, Krishna V, Levy, Ronald, Jacobsen, Eric D, Witzig, Thomas E, Reagan, Patrick, Bot, Adrian, Rossi, John, Navale, Lynn, Jiang, Yizhou, Aycock, Jeff, Elias, Meg, Chang, David, Wiezorek, Jeff, Go, William Y

Volltext

ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma von Singh, R R, Kunkalla, K, Qu, C, Schlette, E, Neelapu, S S, Samaniego, F, Vega, F

Volltext

Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial von Wang, M, Fowler, N, Wagner-Bartak, N, Feng, L, Romaguera, J, Neelapu, S S, Hagemeister, F, Fanale, M, Oki, Y, Pro, B, Shah, J, Thomas, S, Younes, A, Hosing, C, Zhang, L, Newberry, K J, Desai, M, Cheng, N, Badillo, M, Bejarano, M, Chen, Y, Young, K H, Champlin, R, Kwak, L, Fayad, L

Volltext

CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR ASPERGILLOSIS von Kumar, P., Wurster, S., daSilva, T., Hauser, P., Neelapu, S.S., Kontoyiannis, D.

Volltext

Bridging Radiotherapy prior to Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma von Fetooh, A., Lionel, A., Fang, P., Nze, C.C., Ahmed, S., Westin, J., Flowers, C., Pinnix, C.C., Dabaja, B., Gunther, J.R., Neelapu, S.S., Wang, M.L., Jain, P., Wu, S.Y.

Volltext

Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapy von Nair, Ranjit, Drillet, Gaëlle, Lhomme, Faustine, Le Bras, Anthony, Michel, Laure, Rossi, John, Sherman, Marika, Xue, Allen, Kerber, Anne, Jittapiromsak, Nutchawan, Chi, Linda, Tummala, Sudhakar, Neelapu, Sattva S, Houot, Roch

Volltext

Outcomes with Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Pts with Aggressive B Cell Lymphomas von Manzar, G.S., Wu, S.Y., Dudzinski, S.O., Jallouk, A., Yoder, A.K., Nasr, L.F., Corrigan, K.L., Gunther, J.R., Ahmed, S., Fayad, L., Nair, R., Steiner, R., Westin, J., Neelapu, S.S., Dabaja, B., Strati, P., Nastoupil, L., Pinnix, C.C., Fang, P., Rooney, M.K.

Volltext

Ultra Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung von Wu, S.Y., Gunther, J.R., Manzar, G.S., Corrigan, K.L., Damron, E.P., Schrank, B.R., Nasr, L.F., Chihara, D., Malpica Castillo, L.E., Nair, R., Steiner, R., Jain, P., Neelapu, S.S., Samaniego, F., Rodriguez, M.A., Strati, P., Nastoupil, L., Dabaja, B., Pinnix, C.C., Fang, P.

Volltext

Outcomes and Toxicities in Patients with Diffuse Large B-Cell Lymphoma of the Gastrointestinal Tract von Cha, E., Manzar, G.S., Corrigan, K.L., Yoder, A.K., Schrank, B.R., Nasr, L.F., Gunther, J.R., Strati, P., Ahmed, S., Fayad, L., Nair, R., Steiner, R., Westin, J., Nastoupil, L., Neelapu, S.S., Pinnix, C.C., Dabaja, B., Wu, S.Y., Fang, P.

Volltext

Characterization of Lymphopenia during Bridging Radiation Therapy Prior to CAR-T Cell Therapy in Patients with Aggressive B Cell Lymphomas von Manzar, G.S., Wu, S.Y., Dudzinski, S.O., Rooney, M.K., Jallouk, A., Yoder, A.K., Nasr, L.F., Gunther, J.R., Sallard, G., Ahmed, S., Fayad, L., Nair, R., Steiner, R., Westin, J., Nastoupil, L., Neelapu, S.S., Dabaja, B., Pinnix, C.C., Strati, P., Fang, P.

Volltext

Partial Omission of Bleomycin for Early Stage Hodgkin Lymphoma Patients Treated with Combined Modality Therapy: Does Incomplete ABVD Lead to Inferior Outcomes? von Gunther, J.R., Pinnix, C.C., Glober, G., Christopherson, K.M., Lee, H., Ahmed, S., Steiner, R.E., Nair, R., Strati, P., Neelapu, S.S., Nastoupil, L., Dabaja, B.

Volltext

Patients with classical Hodgkin lymphoma experiencing disease progression after treatment with brentuximab vedotin have poor outcomes von Cheah, C.Y., Chihara, D., Horowitz, S., Sevin, A., Oki, Y., Zhou, S., Fowler, N.H., Romaguera, J.E., Turturro, F., Hagemeister, F.B., Fayad, L.E., Wang, M., Neelapu, S.S., Nastoupil, L.J., Westin, J.R., Rodriguez, M.A., Samaniego, F., Anderlini, P., Nieto, Y., Fanale, M.A.

Volltext

Primary Gastric Diffuse Large B-Cell Lymphoma Treated with Abbreviated Chemoimmunotherapy and Contemporary Radiation Therapy has Excellent Outcomes with Minimal Toxicity von Christopherson, K.M., Gunther, J.R., Milgrom, S.A., Wong, P.F., Ning, M.S., Nastoupil, L., Neelapu, S.S., Fowler, N., Fanale, M.A., Westin, J., Oki, Y., Khoury, J., Dabaja, B., Pinnix, C.C.

Volltext

Factors influencing outcome in advanced stage, low-grade follicular lymphoma treated at MD Anderson Cancer Center in the rituximab era von Cheah, C.Y., Chihara, D., Ahmed, M., Davis, R.E., Nastoupil, L.J., Phansalkar, K., Hagemeister, F.B., Fayad, L.E., Westin, J.R., Oki, Y., Fanale, M.A., Romaguera, J.E., Wang, M.L., Lee, H., Turturro, F., Samaniego, F., Rodriguez, M.A., Neelapu, S.S., Fowler, N.H.

Volltext

Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma von Esmaeli, B., McLaughlin, P., Pro, B., Samaniego, F., Gayed, I., Hagemeister, F., Romaguera, J., Cabanillas, F., Neelapu, S. S., Banay, R., Fayad, L., Wayne Saville, M., Kwak, L. W.

Volltext

Limited Utility of PET-CT and CT Imaging Beyond Treatment Completion in Limited Stage Hodgkin Lymphoma Patients von Glober, G., Gunther, J.R., Milgrom, S.A., Korivi, B.R., Jensen, C.T., Wagner-Bartak, N.A., Lee, H., Ahmed, S., Nair, R., Steiner, R.E., Iyer, S.P., Westin, J., Fayad, L., Rodriguez, M.A., Neelapu, S.S., Nastoupil, L., Dabaja, B., Pinnix, C.C.

Volltext

Impact of Cell of Origin, MYC/BCL2 Dual Expression and MYC Rearrangements in Diffuse Large B-Cell Lymphoma Patients Treated with Combined Modality Therapy von Augustyn, A., Gunther, J.R., Medeiros, L.J., Milgrom, S.A., Nastoupil, L., Neelapu, S.S., Nair, R., Li, S., Ok, C.Y., Steiner, R.E., Iyer, S.P., Ahmed, S., Westin, J., Rodriguez, M.A., Pasalic, D., Fayad, L., Samaniego, F., Dabaja, B., Pinnix, C.C.

Volltext

Baseline PET-CT Does Not Predict Outcome in Localized, Low Tumor Burden Follicular Lymphoma von Ayoub, Z., Andraos, T.Y., Pinnix, C.C., Dabaja, B., Nastoupil, L., Mawlawi, O.R., Ng, S.P., Fowler, N., Neelapu, S.S., Samaniego, F., Fayad, L., Milgrom, S.A.

Volltext